Abbott Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	44,328	41,950	40,109	43,653	43,075
Revenue Growth (YoY)	5.67%	4.59%	-8.12%	1.34%	24.46%
Cost of Revenue	19,188	18,644	17,919	19,083	18,080
Gross Profit	25,140	23,306	22,190	24,570	24,995
Selling, General & Admin	12,179	11,109	10,385	10,703	11,006
Research & Development	2,885	2,823	2,619	2,741	2,738
Amortization of Goodwill & Intangibles	1,682	1,878	1,966	2,013	2,047
Operating Expenses	16,746	15,810	14,970	15,457	15,791
Operating Income	8,394	7,496	7,220	9,113	9,204
Interest Expense	-185	-559	-637	-558	-533
Interest & Investment Income	-	344	385	183	43
Currency Exchange Gain (Loss)	50	27	-41	-2	-1
Other Non Operating Income (Expenses)	577	-166	-22	-85	7
EBT Excluding Unusual Items	8,836	7,142	6,905	8,651	8,720
Merger & Restructuring Charges	-370	-129	-144	-234	-509
Gain (Loss) on Sale of Investments	-	-	-39	-	-
Asset Writedown	-	-	-100	-111	-
Other Unusual Items	-	-	42	-	-
Pretax Income	8,466	7,013	6,664	8,306	8,211
Income Tax Expense	1,942	-6,389	941	1,373	1,140
Earnings From Continuing Operations	6,524	13,402	5,723	6,933	7,071
Net Income	6,524	13,402	5,723	6,933	7,071
Preferred Dividends & Other Adjustments	-	51	22	28	29
Net Income to Common	6,524	13,351	5,701	6,905	7,042
Net Income Growth	-51.32%	134.18%	-17.45%	-1.95%	57.31%
Shares Outstanding (Basic)	1,749	1,740	1,740	1,753	1,775
Shares Outstanding (Diluted)	1,749	1,748	1,749	1,764	1,789
Shares Change (YoY)	0.06%	-0.06%	-0.85%	-1.40%	0.17%
EPS (Basic)	3.73	7.67	3.28	3.94	3.97
EPS (Diluted)	3.72	7.64	3.26	3.91	3.94
EPS Growth	-51.31%	134.36%	-16.62%	-0.76%	57.38%
Free Cash Flow	-	6,351	5,059	7,804	8,648
Free Cash Flow Per Share	-	3.63	2.89	4.42	4.83
Dividend Per Share	2.400	2.240	2.080	1.920	1.820
Dividend Growth	7.14%	7.69%	8.33%	5.50%	18.95%
Gross Margin	56.71%	55.56%	55.32%	56.28%	58.03%
Operating Margin	18.94%	17.87%	18.00%	20.88%	21.37%
Profit Margin	14.72%	31.83%	14.21%	15.82%	16.35%
Free Cash Flow Margin	-	15.14%	12.61%	17.88%	20.08%
EBITDA	11,493	10,714	10,463	12,380	12,742
EBITDA Margin	25.93%	25.54%	26.09%	28.36%	29.58%
D&A For EBITDA	3,099	3,218	3,243	3,267	3,538
EBIT	8,394	7,496	7,220	9,113	9,204
EBIT Margin	18.94%	17.87%	18.00%	20.88%	21.37%
Effective Tax Rate	22.94%	-	14.12%	16.53%	13.88%

Updated Jan 22, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q